Dr. Angela DeMichelle (IMAGE)
Caption
ANGELA M. DEMICHELE, MD, MSCE, A PRECOG INVESTIGATOR ON THE PATINA TRIAL, NOTED THAT PALBOCICLIB, A WELL-TOLERATED ORAL MEDICINE, SIGNIFICANTLY EXTENDS RESPONSE TIME AND DISEASE CONTROL IN PATIENTS WITH A CURRENTLY INCURABLE DISEASE
Credit
Penn Medicine
Usage Restrictions
No restrictions.
License
CC0